ES551501A0 - Un procedimiento para la preparacion de nuevas 4(3h)-piri-midonas 2,5 disustituidas - Google Patents
Un procedimiento para la preparacion de nuevas 4(3h)-piri-midonas 2,5 disustituidasInfo
- Publication number
- ES551501A0 ES551501A0 ES551501A ES551501A ES551501A0 ES 551501 A0 ES551501 A0 ES 551501A0 ES 551501 A ES551501 A ES 551501A ES 551501 A ES551501 A ES 551501A ES 551501 A0 ES551501 A0 ES 551501A0
- Authority
- ES
- Spain
- Prior art keywords
- midonas
- disstituted
- piri
- procedure
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/534,426 US4772704A (en) | 1983-09-21 | 1983-09-21 | 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES551501A0 true ES551501A0 (es) | 1987-01-16 |
| ES8702897A1 ES8702897A1 (es) | 1987-01-16 |
Family
ID=24129972
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES536054A Expired ES8607253A1 (es) | 1983-09-21 | 1984-09-19 | Un procedimiento para la preparacion de nuevos 4 (3h)-pirimidonas 2,5-disustituidas. |
| ES544213A Expired ES8704465A1 (es) | 1983-09-21 | 1985-06-14 | Un procedimiento para la preparacion de nuevas 4 (3h)-piri- midonas 2,5-disustituidas |
| ES551501A Expired ES8702897A1 (es) | 1983-09-21 | 1986-01-31 | Un procedimiento para la preparacion de nuevas 4(3h)-piri-midonas 2,5 disustituidas |
| ES551500A Expired ES8704155A1 (es) | 1983-09-21 | 1986-01-31 | Un procedimiento para la preparacion de nuevas 4(3h)-piri-midonas 2,5 disustituidas |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES536054A Expired ES8607253A1 (es) | 1983-09-21 | 1984-09-19 | Un procedimiento para la preparacion de nuevos 4 (3h)-pirimidonas 2,5-disustituidas. |
| ES544213A Expired ES8704465A1 (es) | 1983-09-21 | 1985-06-14 | Un procedimiento para la preparacion de nuevas 4 (3h)-piri- midonas 2,5-disustituidas |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES551500A Expired ES8704155A1 (es) | 1983-09-21 | 1986-01-31 | Un procedimiento para la preparacion de nuevas 4(3h)-piri-midonas 2,5 disustituidas |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US4772704A (es) |
| JP (1) | JPH0643310B2 (es) |
| KR (1) | KR900001198B1 (es) |
| AR (2) | AR242385A1 (es) |
| AT (1) | AT387965B (es) |
| AU (1) | AU583479B2 (es) |
| BE (1) | BE900652A (es) |
| CA (1) | CA1260463A (es) |
| CH (1) | CH665840A5 (es) |
| CS (1) | CS249147B2 (es) |
| CY (1) | CY1561A (es) |
| DD (1) | DD226881A5 (es) |
| DE (1) | DE3434578A1 (es) |
| DK (1) | DK162987C (es) |
| ES (4) | ES8607253A1 (es) |
| FI (1) | FI83868C (es) |
| FR (1) | FR2552082B1 (es) |
| GB (1) | GB2146994B (es) |
| GR (1) | GR80439B (es) |
| HK (1) | HK73790A (es) |
| HU (1) | HU193227B (es) |
| IE (1) | IE58083B1 (es) |
| IL (1) | IL72990A (es) |
| IT (1) | IT1176739B (es) |
| LU (1) | LU85550A1 (es) |
| NL (1) | NL8402898A (es) |
| NO (1) | NO161561C (es) |
| NZ (1) | NZ209572A (es) |
| OA (1) | OA07820A (es) |
| PT (1) | PT79256B (es) |
| SE (1) | SE463209B (es) |
| SG (1) | SG60890G (es) |
| YU (1) | YU45205B (es) |
| ZA (1) | ZA847345B (es) |
| ZM (1) | ZM4984A1 (es) |
| ZW (1) | ZW16084A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2873340B2 (ja) * | 1988-04-29 | 1999-03-24 | 武田薬品工業株式会社 | 抗生物質ｔａｎ―１０５７，その製造法および用途 |
| EP4196793A1 (en) | 2020-08-11 | 2023-06-21 | Université de Strasbourg | H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN151188B (es) * | 1978-02-13 | 1983-03-05 | Smith Kline French Lab | |
| ES477520A1 (es) * | 1978-02-25 | 1979-06-01 | Thomae Gmbh Dr K | Procedimiento para la preparacion de nuevas penicilinas. |
| AU527202B2 (en) * | 1978-04-11 | 1983-02-24 | Smith Kline & French Laboratories Limited | 2-aminopyrimidones |
| US4496567A (en) * | 1978-11-13 | 1985-01-29 | Smith Kline & French Laboratories Limited | Phenyl alkylaminopyrimidones |
| US4521418A (en) * | 1979-02-21 | 1985-06-04 | Smith Kline & French Laboratories Limited | Guanidinothiazolyl derivatives |
| AU531142B2 (en) * | 1979-04-04 | 1983-08-11 | Smith Kline & French Laboratories Limited | 2 amino- pyimindones |
| CA1140129A (en) * | 1979-08-21 | 1983-01-25 | Ronald J. King | 4-pyrimidone derivatives |
| ZW21281A1 (en) * | 1980-10-01 | 1981-11-18 | Smith Kline French Lab | Amine derivatives |
| US4352933A (en) * | 1981-02-06 | 1982-10-05 | Smithkline Beckman Corporation | Chemical methods and intermediates for preparing substituted pyrimidinones |
| US4468399A (en) * | 1981-12-28 | 1984-08-28 | Eli Lilly And Company | 2-[2-(2-Aminoalkyl-4-thiazolylmethylthio)alkyl]-amino-5-substituted-4-pyrimidones |
| NZ202797A (en) * | 1981-12-28 | 1985-08-30 | Lilly Co Eli | Pyrimidine derivatives and pharmaceutical compositions |
| GB8320505D0 (en) * | 1983-07-29 | 1983-09-01 | Smith Kline French Lab | Chemical compounds |
| CA1275097A (en) * | 1984-10-02 | 1990-10-09 | Fujio Nohara | Pyridyloxy derivatives |
-
1983
- 1983-09-21 US US06/534,426 patent/US4772704A/en not_active Expired - Fee Related
-
1984
- 1984-09-17 NZ NZ209572A patent/NZ209572A/en unknown
- 1984-09-18 FI FI843643A patent/FI83868C/fi not_active IP Right Cessation
- 1984-09-18 IL IL72990A patent/IL72990A/xx not_active IP Right Cessation
- 1984-09-18 ZW ZW160/84A patent/ZW16084A1/xx unknown
- 1984-09-18 ZM ZM49/84A patent/ZM4984A1/xx unknown
- 1984-09-18 ZA ZA847345A patent/ZA847345B/xx unknown
- 1984-09-19 ES ES536054A patent/ES8607253A1/es not_active Expired
- 1984-09-19 NO NO843726A patent/NO161561C/no unknown
- 1984-09-19 YU YU1613/84A patent/YU45205B/xx unknown
- 1984-09-19 CA CA000463533A patent/CA1260463A/en not_active Expired
- 1984-09-20 JP JP59195868A patent/JPH0643310B2/ja not_active Expired - Lifetime
- 1984-09-20 AU AU33351/84A patent/AU583479B2/en not_active Ceased
- 1984-09-20 DE DE19843434578 patent/DE3434578A1/de not_active Withdrawn
- 1984-09-20 HU HU843539A patent/HU193227B/hu not_active IP Right Cessation
- 1984-09-20 CS CS847103A patent/CS249147B2/cs unknown
- 1984-09-20 GB GB08423863A patent/GB2146994B/en not_active Expired
- 1984-09-20 SE SE8404729A patent/SE463209B/sv not_active IP Right Cessation
- 1984-09-20 FR FR8414463A patent/FR2552082B1/fr not_active Expired
- 1984-09-20 DK DK450484A patent/DK162987C/da active
- 1984-09-20 IT IT22744/84A patent/IT1176739B/it active
- 1984-09-20 CH CH4510/84A patent/CH665840A5/de not_active IP Right Cessation
- 1984-09-20 IE IE240684A patent/IE58083B1/en not_active IP Right Cessation
- 1984-09-20 OA OA58396A patent/OA07820A/xx unknown
- 1984-09-21 KR KR1019840005791A patent/KR900001198B1/ko not_active IP Right Cessation
- 1984-09-21 NL NL8402898A patent/NL8402898A/nl not_active Application Discontinuation
- 1984-09-21 AR AR84298041A patent/AR242385A1/es active
- 1984-09-21 BE BE0/213705A patent/BE900652A/fr not_active IP Right Cessation
- 1984-09-21 PT PT79256A patent/PT79256B/pt not_active IP Right Cessation
- 1984-09-21 DD DD84267496A patent/DD226881A5/de not_active IP Right Cessation
- 1984-09-21 GR GR80439A patent/GR80439B/el unknown
- 1984-09-21 LU LU85550A patent/LU85550A1/fr unknown
- 1984-09-21 AT AT0300984A patent/AT387965B/de not_active IP Right Cessation
-
1985
- 1985-06-14 ES ES544213A patent/ES8704465A1/es not_active Expired
-
1986
- 1986-01-31 ES ES551501A patent/ES8702897A1/es not_active Expired
- 1986-01-31 ES ES551500A patent/ES8704155A1/es not_active Expired
-
1987
- 1987-09-18 AR AR87308766A patent/AR242789A1/es active
-
1990
- 1990-07-21 SG SG608/90A patent/SG60890G/en unknown
- 1990-09-20 HK HK737/90A patent/HK73790A/xx unknown
-
1991
- 1991-03-22 CY CY1561A patent/CY1561A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES510449A0 (es) | Un procedimiento para la preparacion de 1,2,4-triazolonas.fenoxial-quilicas. | |
| ES538256A0 (es) | Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol. | |
| ES513366A0 (es) | Un procedimiento para la preparacion de nuevas n-aril-piperazin alcanamidas. | |
| ES533753A0 (es) | Un procedimiento para la preparacion de nuevas fenoxialquil-1-2-4-triazolonas. | |
| ES511123A0 (es) | Un procedimiento para la preparacion de un dihidroxi-compuesto. | |
| ES542703A0 (es) | Un procedimiento para la preparacion de derivados de tiazol,2, 4, disustituidos. | |
| ES530418A0 (es) | Un procedimiento para la preparacion de pirazolopiridinas. | |
| ES511663A0 (es) | Un procedimiento para la preparacion de un heteropoliacido. | |
| ES510354A0 (es) | Un procedimiento para la preparacion de 2,3-dicloro-5-triclorometilpiridina. | |
| ES509312A0 (es) | Un procedimiento para la preparacion de 1-3-hidroxi-4-metoxibenzoil-3-hidroxi-2-pirrolidinona. | |
| ES501077A0 (es) | Un procedimiento para la preparacion de 4-alquil-sustituido-3--hidroxi-3-pirrolin-2,5 dionas. | |
| ES501432A0 (es) | Un procedimiento para la preparacion de 4,5-diaril-&-cpolifluoralquil)-1-4-pirrol-2metanaminas antiinflamatorias. | |
| ES509432A0 (es) | Un procedimiento para la preparacion de arilaminas. | |
| ES547205A0 (es) | Un procedimiento para la preparacion de nuevas quinazolindionas. | |
| ES533389A0 (es) | Un procedimiento para la preparacion de nuevos derivados de tiosulfonamida. | |
| ES515305A0 (es) | "un procedimiento para la preparacion de o-alquil s,s-dialquil fosforoditioatos". | |
| ES535551A0 (es) | Un procedimiento para la preparacion de nuevos 16-fluor-16,17-dideshidro prostanoides. | |
| ES531760A0 (es) | Un metodo para la preparacion de 1,8-dihidroxi-10-acil-9-antronas. | |
| ES528225A0 (es) | Un procedimiento para la preparacion de nuevos derivados de 1,2,5,-tidiazol. | |
| ES534269A0 (es) | Un procedimiento para la preparacion de nuevos derivados de difeniletanona. | |
| ES535966A0 (es) | Un procedimiento para la preparacion de nuevos derivados de 4,5-dihidro-2h-piridazin-3-ona. | |
| ES536687A0 (es) | Un procedimiento para la preparacion de nuevos derivados de 2-azaciclos alquiltiopenen. | |
| ES537359A0 (es) | Un procedimiento para la preparacion de nuevos derivados de feniletanamina. | |
| ES532777A0 (es) | Un procedimiento para la preparacion de aricoxicicloalcanolaminolaminoalquilen-aril-cetonas. | |
| ES540132A0 (es) | Un procedimiento para la preparacion de 1,4-aminoalquilamino-9-h-tioxaten-9-onas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 19970519 |